Evidence map›Paper›PMID 33704649›Full record

ArticleNeurochemical research2021

Extracellular α-Synuclein Modulates Iron Metabolism Related Proteins via Endoplasmic Reticulum Stress in MES23.5 Dopaminergic Cells.

Xiaoqing Mi, Qijun Li, Xiaoming Wen, Junxia Xie, Youcui Wang, Ning Song

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Xiaoqing Mi *Department of Physiology, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Institute of Brain Science and Disease, Medical College of Qingdao University, Qingdao, 266071, China.
Qijun Li *Department of Physiology, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Institute of Brain Science and Disease, Medical College of Qingdao University, Qingdao, 266071, China.
Xiaoming WenDepartment of Physiology, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Institute of Brain Science and Disease, Medical College of Qingdao University, Qingdao, 266071, China.
Junxia XieDepartment of Physiology, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Institute of Brain Science and Disease, Medical College of Qingdao University, Qingdao, 266071, China.
Youcui WangDepartment of Physiology, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Institute of Brain Science and Disease, Medical College of Qingdao University, Qingdao, 266071, China. wangyoucui1987@163.com.
Ning SongDepartment of Physiology, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Institute of Brain Science and Disease, Medical College of Qingdao University, Qingdao, 266071, China. ningsong@qdu.edu.cn.ORCID http://orcid.org/0000-0002-4399-2236
Qingdao University · CN

Funding

National Natural Science Foundation of China 31771124National Natural Science Foundation of China 31871049
6 · The paper itself

Abstract

Alpha-synuclein plays a vital role in the pathology of Parkinson's disease (PD). Spreading of α-synuclein in neighboring cells was believed to contribute to progression in PD. How α-synuclein transmission affects adjacent cells is not full elucidated. Here, we used recombinant α-synuclein to mimic intercellular transmitted α-synuclein in MES23.5 dopaminergic cells, to investigate whether and how it could modulate iron metabolism. The results showed that α-synuclein treatment up-regulated divalent metal transporter 1 (DMT1) and down-regulated iron transporter (FPN), also up-regulated iron regulatory protein 1 (IRP1) protein levels and hepcidin mRNA levels. Endocytosis inhibitor dynasore pretreatment completely abolished and even reversed the upregulation of DMT1 and IRP1 induced by α-synuclein, however, FPN down-regulation was partially blocked by dynasore. Autophagy-inducing agent rapamycin reversed DMT1 up-regulation and FPN down-regulation, and fully blocked the upregulation of IRP1. Elevated hepcidin levels induced by α-synuclein was fully blocked by dynasore pretreatment, however, even higher with rapamycin pretreatment. Alpha-synuclein treatment triggered endoplasmic reticulum (ER) stress. ER stress inducer thapsigargin induced similar responses elicited by α-synuclein. ER stress inhibitor salubrinal blocked the up-regulation of IRP1 and hepcidin, as well as DMT1 up-regulation and FPN down-regulation, also dramatically abolished cAMP-response elements binding protein phosphorylation induced by α-synuclein. Taken together, these finding indicated that extracellular α-synuclein could regulate cellular iron metabolism, probably mediated by ER stress. It provides novel evidence to elucidate the relationships between transmitted α-synuclein and iron metabolism disturbance in PD.

Indexed as

alpha-SynucleinAnimalsAutophagyCation Transport ProteinsCell Line, TumorCyclic AMP Response Element-Binding ProteinDown-RegulationEndocytosisEndoplasmic Reticulum StressHepcidinsHydrazonesIron Regulatory Protein 1MicePhosphorylationRatsSirolimusalpha-SynucleinCation Transport ProteinsCyclic AMP Response Element-Binding ProteinHamp protein, ratHepcidinsHydrazonesIron Regulatory Protein 1N'-(3,4-dihydroxybenzylidene)-3-hydroxy-2-naphthahydrazideSirolimusSolute Carrier Family 11, Member 2Alpha-synucleinEndoplasmic reticulum stressIronParkinson’s disease

Identifiers

PMID33704649
OpenAlexW3135873493

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.